Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines set out in the Schedule hereto:
Schedule
Product: Clearblue Digital Pregnancy Test
Active Ingredients: Anti-alpha TSH monoclonal antibody 0.778µg
Anti-beta HCG monoclonal antibody 1.08µg
Dosage Form: Pregnancy test kit
New Zealand Sponsor: Pfizer Consumer Healthcare Div. of Pfizer New Zealand Limited
Manufacturer: Unipath Ltd, Priory Business Park, Bedford, United Kingdom
Product: Oxycontin
Active Ingredient: Oxycodone hydrochloride 5mg equivalent to 4.5mg of oxycodone base
Dosage Form: Modified release tablet
New Zealand Sponsor: Mundipharma New Zealand Limited
Manufacturer: Bard Pharmaceuticals Limited, Cambridge Science Park, Cambridge, United Kingdom
Product: ReFacto
Active Ingredient: Moroctocog alfa 2,000IU
Dosage Form: Powder for injection
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturers: Biovitrum AB., Stockholm, Sweden
Wyeth Farma S.A., San Sebastian de los Reyes, Madrid, Spain
Dated this 23rd day of June 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).